ArticleOncology letters2026

Potential treatment benefits of a GLP-1R antagonist in combination with immune checkpoint inhibitors in colorectal cancer.

Zengqin Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.